MHG Stock Chart & Stats
€172.55
€1.70(1.00%)
At close: 4:00 PM EDT
€172.55
€1.70(1.00%)
Day’s Range― - ―
52-Week Range€102.00 - €215.90
Previous CloseN/A
Volume1.01K
Average Volume (3M)226.00
Market Cap
€8.85B
Enterprise Value€15.69K
Total Cash (Recent Filing)€8.91B
Total Debt (Recent Filing)€3.95B
Price to Earnings (P/E)1222.6
Beta-0.10
Next Earnings
Oct 28, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.16
Shares Outstanding52,200,000
10 Day Avg. Volume240
30 Day Avg. Volume226
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)2.17
Price to Sales (P/S)0.19
P/FCF Ratio-13.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€188.95Price Target Upside9.50% Upside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)4.6
Revenue Forecast (FY)€39.14B
Bulls Say, Bears Say
Bulls Say
Core Medicaid & Medicare Duals StrengthConsistent outperformance in Medicaid and Medicare duals reflects durable scale in government programs, favorable rate leverage, and improved MCRs. These segments generate predictable, contract-backed premium flows and margin expansion potential as rate updates and medical-cost control compound over multiple years.
High Reprocurement Win Rate And Contract WinsA >90% reprocurement win rate and recent large contract awards provide durable revenue visibility and scale advantages. Long-term managed Medicaid contracts lock in membership and premium streams, lowering sales volatility and supporting predictable cash flows across multi-year state programs.
G&A Discipline And Scale-driven EfficiencySustained focus on administrative efficiency and planned AI-driven productivity can lower fixed-cost leverage per member as membership grows. Durable reductions in G&A protect margins against medical-cost volatility and support long-term operating leverage as premium base rises toward management’s $64B target.
Bears Say
Volatile Cash GenerationIntermittent negative operating and free cash flow in 2025 highlights working-capital and timing sensitivity inherent in managed care. Volatile cash generation constrains capital allocation, raises refinancing risk during downturns, and reduces resilience to policy or claims shocks over the medium term.
Rising Leverage And Reduced Balance-sheet FlexibilityHigher leverage (debt-to-equity ≈1.0; debt-to-cap ~47%) increases sensitivity to margin compression and cash-flow volatility. Elevated debt limits strategic optionality, amplifies downside risk from contract or regulatory setbacks, and raises funding costs if operating performance deteriorates.
Marketplace, MAPD Losses And Florida CMS Implementation DragStructural losses in Marketplace and MAPD plus a substantive implementation drag from the Florida CMS contract represent multi-quarter headwinds. These product and implementation exposures compress earnings and require execution to mitigate, increasing uncertainty in near-to-medium-term margin recovery.
Molina Healthcare News
MHG FAQ
What was Molina Healthcare’s price range in the past 12 months?
Molina Healthcare lowest stock price was €102.00 and its highest was €215.90 in the past 12 months.
What is Molina Healthcare’s market cap?
Molina Healthcare’s market cap is €8.85B.
When is Molina Healthcare’s upcoming earnings report date?
Molina Healthcare’s upcoming earnings report date is Oct 28, 2026 which is in 87 days.
How were Molina Healthcare’s earnings last quarter?
Molina Healthcare released its earnings results on Jul 22, 2026. The company reported €1.309 earnings per share for the quarter, beating the consensus estimate of €1.206 by €0.103.
Is Molina Healthcare overvalued?
According to Wall Street analysts Molina Healthcare’s price is currently Undervalued.
Does Molina Healthcare pay dividends?
Molina Healthcare does not currently pay dividends.
What is Molina Healthcare’s EPS estimate?
Molina Healthcare’s EPS estimate is 0.71.
How many shares outstanding does Molina Healthcare have?
Molina Healthcare has 52,200,000 shares outstanding.
What happened to Molina Healthcare’s price movement after its last earnings report?
Molina Healthcare reported an EPS of €1.309 in its last earnings report, beating expectations of €1.206. Following the earnings report the stock price went down -13.34%.
Which hedge fund is a major shareholder of Molina Healthcare?
Currently, no hedge funds are holding shares in DE:MHG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Molina Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€188.95 (9.50% Upside)
€188.95 (9.50% Upside)
Blogger Sentiment
Bullish
DE:MHG Sentiment 77%
Sector Average 65%
Sector Average 65%
Insider Transactions
Sold Shares
Worth $3.4M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.27%
Trailing 12-Months
Company Description
Molina Healthcare
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
MHG Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a generally constructive tone: core businesses (Medicaid and Medicare duals) performed well and management raised 2026 EPS guidance, highlighted strong cash generation, contract wins, and a clear path to long-term targets. However, material near-term headwinds remain in the Marketplace line (higher-than-expected MCR, adverse acuity mix and prior-year items), a discrete MAPD loss, and the one-time Florida CMS implementation drag. Management frames these negatives as largely nonrecurring and manageable, emphasizing scale, rate leverage, embedded earnings and MCR improvements as the route to 2027-2029 targets.View all DE:MHG earnings summariesMHG Revenue Breakdown
70.97% Medicaid
13.73% Medicare
9.88% Marketplace
0.39% Other
5.03% Other operating revenues
MHG Stock 12 Month Forecast
Average Price Target
€188.95
▲(9.50% Upside)